Auranofin, as an anti-rheumatic gold compound, suppresses LPS-induced homodimerization of TLR4.
about
Pattern recognition receptors as potential therapeutic targets in inflammatory rheumatic diseaseMercury induces the expression of cyclooxygenase-2 and inducible nitric oxide synthaseMetal complexes as potential modulators of inflammatory and autoimmune responses.Effect of 2-chloro-substitution of adenine moiety in mixed-ligand gold(I) triphenylphosphine complexes on anti-inflammatory activity: the discrepancy between the in vivo and in vitro models.Free thiol group of MD-2 as the target for inhibition of the lipopolysaccharide-induced cell activationTherapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer.Anticancer activity of metal complexes: involvement of redox processes.The biological activity of auranofin: implications for novel treatment of diseases.Chloroquine and beyond: exploring anti-rheumatic drugs to reduce immune hyperactivation in HIV/AIDS.Garlic (Allium sativum) extract inhibits lipopolysaccharide-induced Toll-like receptor 4 dimerization.Annexin A5 suppresses cyclooxygenase-2 expression by downregulating the protein kinase C-ζ-nuclear factor-κB signaling pathway in prostate cancer cells.Suppression of Toll-Like Receptor 4 Dimerization by 1-[5-Methoxy-2-(2-nitrovinyl)phenyl]pyrrolidine.Tetrathiomolybdate Treatment Leads to the Suppression of Inflammatory Responses through the TRAF6/NFκB Pathway in LPS-Stimulated BV-2 Microglia.NF-κB signaling and its relevance to the treatment of mantle cell lymphoma.
P2860
Q28084262-3C4AABEA-1869-4746-B144-3BB66C2A786FQ28252899-C70A3BCA-67DB-4300-ACC5-53E46F4BE85FQ33805225-752470C3-7AF5-45B7-9B41-5857C3E4FFB0Q35060920-1F299C83-EBFD-4A5A-95B4-B3D87AC2FAA0Q37339321-34EB3815-C7BB-4D6A-84A8-B9D7A8C74EABQ37497786-94EBAA9A-F5D4-4C95-BEDA-D204F24E670DQ37833099-AA034418-ACEF-47CD-85AE-141761BA2D24Q38042341-F67AEB8F-662B-4F96-89F3-CE04BCC91DFAQ38530430-F9E9DD38-8B22-4BC2-913D-3268AE5F1C5FQ40015676-4BCFD24D-4844-4DD9-8423-D413694BAC13Q47106383-BF86CEF3-530F-4618-94F0-E89906125EDEQ51576691-9C3CC276-4164-4A10-986B-0CFF229BE236Q51763391-CF44742C-A05E-4EDC-A7AF-2C59F1AB63A3Q55427997-5FB90B01-77DB-4414-ABFF-8822DEE79C8E
P2860
Auranofin, as an anti-rheumatic gold compound, suppresses LPS-induced homodimerization of TLR4.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 September 2006
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Auranofin, as an anti-rheumati ...... uced homodimerization of TLR4.
@en
Auranofin, as an anti-rheumati ...... uced homodimerization of TLR4.
@nl
type
label
Auranofin, as an anti-rheumati ...... uced homodimerization of TLR4.
@en
Auranofin, as an anti-rheumati ...... uced homodimerization of TLR4.
@nl
prefLabel
Auranofin, as an anti-rheumati ...... uced homodimerization of TLR4.
@en
Auranofin, as an anti-rheumati ...... uced homodimerization of TLR4.
@nl
P2093
P2860
P1476
Auranofin, as an anti-rheumati ...... uced homodimerization of TLR4.
@en
P2093
Daniel H Hwang
Hyung S Youn
Kensuke Miyake
Shin I Saitoh
P2860
P304
P356
10.1016/J.BBRC.2006.09.097
P407
P577
2006-09-28T00:00:00Z